SoftOx secures funding through private placement with Long State Investments

SoftOx Solutions AS announced its board of directors resolved on a private placement, with Long State Investments Limited subscribing for 60,000,000 shares at NOK 0.0604 per share. This action follows the financing facility referenced in the company's stock notice from August 14, 2025. Long State also received a placement commission on market terms as part of the financing agreement.

Following this private placement, SoftOx's new share capital will be NOK 47,808,339.88, divided into 2,390,416,994 shares, each with a par value of NOK 0.02. The board justified the deviation from shareholders' preferential rights by citing the need for timely and successful completion to secure funding, considering the time, costs, and expected terms of alternative methods.

The board also concluded against a subsequent offering, deeming it unnecessary given the limited size of the private placement and the associated costs. SoftOx Solutions AS is a clinical-stage pharmaceutical company listed on Euronext Growth Oslo.